Aurobindo Pharma shares in focus after Q3 profit drops 10% YoY. Should you buy or sell?
Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales ...
SBI shares in focus after Q3 PAT beats estimates. Should you buy, sell, or hold?
SBI's net interest income (NII) for Q3FY25 rose by 4.09% YoY, totaling Rs 41,620 crore, compared to Rs 39,816 crore in the ...